#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Glomerulonephritis chronic Astrocytoma Myotonic dystrophy Cardiomyopathy Brain stem glioma Idiopathic inflammatory myopathy Scleroderma associated digital ulcer Gastrooesophageal cancer Chronic granulomatous disease Intracranial calcification Dermatitis Malignant fibrous histiocytoma Lymphangiosarcoma Myxofibrosarcoma Sexually transmitted disease More trials…

    Learn about Rare Diseases

    Thrombotic thrombocytopenic purpura – Treatment Adrenocortical carcinoma – Treatment Ocular melanoma – Treatment Urea cycle disorder Adrenocortical carcinoma – Basic Information Methylmalonic acidaemia – Treatment Haemolytic uraemic syndrome – Diagnostics Myxofibrosarcoma – Life with Disease Isodicentric chromosome 15 syndrome – Treatment Mucopolysaccharidosis – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tofersen Resmetirom T89 Tyra-300-B01 D-Biotin Aluminium Oxide, Hydrated Leuprorelin Lolium Perenne Allopurinol Tiemonium Methylsulphate Pc14586 Cilastatin Botensilimab Epinephrine Bitartrate Oxitriptan Cobolimab Roxadustat Regn7075 Inclisiran Furosemide More therapies…

    Learn about Your Condition

    Osteoporosis postmenopausal Spinal muscular atrophy Cardiogenic shock Foot deformity Allergic respiratory disease Ovarian cancer metastatic Insulin resistance Head injury Thyroidectomy Hypotonia Gingival bleeding Reperfusion injury Sickle cell anaemia Varices oesophageal Vasoplegia syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Clinique Victor Hugo

Clinique Victor Hugo

Centre De Cancerologie De La Sarthe, 64 Rue De Degre, Le Mans, 72000, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study of avelumab and cetuximab combination treatment after TPEx chemotherapy for patients with recurrent or metastatic head and neck cancer receiving first-line therapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Avelumab
    • Carboplatin
    • Cetuximab
    France

  • Study on Zanidatamab and Chemotherapy for Patients with Metastatic HER2-Positive Breast Cancer After Trastuzumab Deruxtecan Treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    • Breast cancer
    Investigated Drugs:
    • Eribulin Mesylate
    • Zanidatamab
    • Capecitabine
    Austria Belgium France Germany Greece Italy +2

  • Study on Darolutamide and Triptorelin for Patients with Localized High-Risk Prostate Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Triptorelin
    • Darolutamide
    France Spain

  • Study of Paclitaxel, Carboplatin, and Bevacizumab with Niraparib for Patients with Advanced Ovarian, Tubal, or Peritoneal Cancer After Surgery

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Bevacizumab
    • Niraparib
    • Niraparib Tosilate Monohydrate
    Belgium France Italy Spain

  • Study on the Effects of Acetylsalicylic Acid and Atorvastatin in Patients with Castration-Resistant Prostate Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Atorvastatin
    • Acetylsalicylic Acid
    Czechia France

  • Study on Lasofoxifene, Fulvestrant, and Abemaciclib for Advanced Breast Cancer in Women and Men with ESR1 Mutation

    Recruiting

    3 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    Investigated Drugs:
    • Lasofoxifene
    • Abemaciclib
    • Fulvestrant
    Belgium France Germany Hungary Italy Poland +2

  • Study Comparing Capsaicin Patch and Duloxetine for Patients with Chemotherapy-Induced Peripheral Neuropathy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Neuropathy peripheral
    Investigated Drugs:
    • Duloxetine
    • Capsaicin
    France

  • Study on Durvalumab and Tremelimumab for Patients with Kidney Cancer at Risk of Recurrence After Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal cell carcinoma
    Investigated Drugs:
    • Tremelimumab
    • Durvalumab
    France Spain

  • Study of Sacituzumab Govitecan and Pembrolizumab for Patients with Triple Negative Breast Cancer with Residual Disease After Surgery and Therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Triple negative breast cancer
    Investigated Drugs:
    • Sacituzumab Govitecan
    • Capecitabine
    • Pembrolizumab
    Belgium France Germany Ireland Italy Spain

  • Study Comparing Imlunestrant with Standard Endocrine Therapy for Patients with Early ER+, HER2- Breast Cancer at Increased Risk of Recurrence

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Ly3484356
    • Anastrozole
    • Exemestane
    Austria Belgium Czechia Finland France Germany +10
Previous Page
1 2 3 4 5 … 9
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!